Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Rejuvenation Research|January 8, 2014
CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapiesAnna French, Kim Bure, David A BrindleyRejuvenation Research|August 26, 2018
Biotechnology Governance 2.0: A Proposal for Minimum Standards in Biotechnology Corporate GovernanceAlison R Carter, Edward Meinert, David A BrindleyRejuvenation Research|March 9, 2013
Commercialization of regenerative medicine: learning from spin-outsAnna French, R Lee Buckler, David A BrindleyRejuvenation Research|June 22, 2021
Gazing Long into a Clinical and Social Abyss? Treating Hypertrophic Scarring and KeloidsAlison R Carter, Benjamin M Davies, David A BrindleyCytotherapy|February 18, 2018
Bioprocessing automation in cell therapy manufacturing: Outcomes of special interest group automation workshopOliver Ball, Sarah Robinson, Kim Bure, et al.Nature Biotechnology|November 10, 2018
The Reporting Items for Patent Landscapes statementJames A Smith, Zeeshaan Arshad, Anthony Trippe, et al.European Journal of Hospital Pharmacy : Science and Practice|February 16, 2018
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacistsPiotr Merks, Damian Swieczkowski, Michal Byliniak, et al.Trends in Biotechnology|August 25, 2014
Global strategic partnerships in regenerative medicineAnna French, Jane Y Suh, Carol Y Suh, et al.Eye (London, England)|July 18, 2019
Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision modelCeline-Lea Halioua-Haubold, Jasleen K Jolly, James A Smith, et al.JPRAS Open|January 10, 2017
Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study qualityZeeshaan Arshad, Lindsey Karmen, Rajan Choudhary, et al.Pageof 3